JEFFREY BERNEY: Open Payments
NPI 1467498170 · HOLDREGE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 33 payments from 12 companies in 2025. Trend: 2023 $475 · 2024 $488 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $157 |
| Astellas Pharma US Inc | 2 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $53 |
| Novo Nordisk Inc | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Abbott Laboratories | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $29 |
| Boston Scientific Corporation | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
Products named: VRAYLAR, Veozah, CAPLYTA, Rybelsus, LEQVIO, FREESTYLE LIBRE 3, Kerendia, BodyGuardian.
Industry payments across NE — which companies pay providers there.
